$34.86−0.30 (−0.85%)
At close: Oct 26, 2026, 4:00 PM ET· Nasdaq · USD
Healthstream (HSTM) Stock Checks
How HSTM measures up against value, income, timing, and long-hold tenets. Every criterion shows the live number and the pass rule. Always free.
Sources Company filings and computed by Tenet Filings and TenetScreens as of How we compute thisNot investment advice
The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).
3 / 17 qualify todayas of Oct 26, 2026 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
3
meet every gate today
BORDERLINE
8
within one input of the gate
FAILS
5
miss at least one gate
UNKNOWN
1
insufficient data to judge
passesfailsborderlineunknown
Value — six classic philosophies
Buffett Qualitydurable moat
~ BorderlineFailsROE ≥ 15%(TTM through Jun 30, 2026)6.0% · ≥ 15.0%
PassesGross margin ≥ 40%(fiscal 2025: trailing figures for Technology are still under review)64.7% · ≥ 40.0%
FailsNet margin ≥ 15%(TTM through Jun 30, 2026)6.6% · ≥ 15.0%
PassesDebt/equity ≤ 0.5(quarter ending Jun 30, 2026)0.00 · ≤ 0.50
PassesGrowing FCF (multi-yr)(fiscal 2020 to 2025)12.8% per year · > 0
Decided by the pass rule for Buffett Quality.The pass rule for Buffett Quality is what decides that verdict, and it is not restated here.Buffett Quality under The screens ›Today's Buffett Quality list ›
Piotroski F-Scorefinancial strength
✕ 5 / 9PassesReturn on assets positive(fiscal 2025)3.5% · > 0
PassesOperating cash flow positive(fiscal 2025)$63.3M · > 0
FailsReturn on assets improving(fiscal 2025)3.9% → 3.5%
PassesEarnings backed by cash (CFO > net income)(fiscal 2025)$63.3M vs $18.3M
FailsLeverage falling (long-term debt / assets)(fiscal 2025)We hold no record of long-term debt as a share of assets for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.no
FailsCurrent ratio improving(fiscal 2025)1.32 → 0.96
PassesNo share dilution (≤ +2%)(fiscal 2025)−1.3%
FailsGross margin expanding(fiscal 2025)66.4% → 64.7%
PassesAsset turnover improving(fiscal 2025)0.57 → 0.58
Decided by the pass rule for Piotroski F-Score.The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here. These checks score 5 of 9. 1 of 9 carry no data.Piotroski F-Score under The screens ›Today's Piotroski F-Score list ›
Munger Compoundershigh-ROIC quality
~ BorderlineFailsROIC ≥ 15%(TTM through Jun 30, 2026)5.6% · ≥ 15.0%
PassesNet debt/EBITDA ≤ 3×(fiscal 2025: trailing figures for Technology are still under review)−0.7× · ≤ 3.0×
PassesAltman Z ≥ 3 (safe zone)(TTM through Jun 30, 2026)4.89 · ≥ 3.00
Decided by the pass rule for Munger Compounders.The pass rule for Munger Compounders is what decides that verdict, and it is not restated here.Munger Compounders under The screens ›Today's Munger Compounders list ›
Magic FormulaROC + earnings yield (threshold check; full rank needs universe)
~ BorderlinePassesEBIT > 0(fiscal 2025: trailing figures for Technology are still under review)$20.2M · > 0
FailsEarnings yield EBIT/EV ≥ 6%(fiscal 2025: trailing figures for Technology are still under review)2.1% · ≥ 6.0%
PassesReturn on capital ≥ 25%(fiscal 2025: trailing figures for Technology are still under review)327.9% · ≥ 25.0%
Decided by the pass rule for Magic Formula.The pass rule for Magic Formula is what decides that verdict, and it is not published separately on the methodology page.About this screen ›Today's Magic Formula® list ›
Graham Defensivemargin of safety
✕ FailsFailsSize: market cap ≥ $2B$1.0B · ≥ $2.0B
FailsCurrent ratio ≥ 2(quarter ending Jun 30, 2026)1.06 · ≥ 2.00
PassesPositive EPS 10y10y
PassesPays a dividend$0.12 · > 0
PassesEPS growth ≥ 3%/yr(fiscal 2020 to 2025)6.8% per year · ≥ 3.0%
FailsP/E ≤ 15(TTM through Jun 30, 2026)49.21 · ≤ 15.00
FailsP/E × P/B ≤ 22.5(TTM through Jun 30, 2026)141.88 · ≤ 22.50
Decided by the pass rule for Graham Defensive.The pass rule for Graham Defensive is what decides that verdict, and it is not restated here.Graham Defensive under The screens ›Today's Graham Defensive list ›
Lynch GARPgrowth at reasonable price (historical-CAGR basis)
✕ FailsFailsPEG < 1 (hist. growth)(P/E TTM through Jun 30, 2026, EPS growth through fiscal 2025)7.29 · < 1.00
FailsEPS growth 10–30%(fiscal 2020 to 2025)6.8% per year · 10.0%–30.0%
Decided by the pass rule for Lynch GARP.The pass rule for Lynch GARP is what decides that verdict, and it is not restated here.Lynch GARP under The screens ›Today's Lynch GARP list ›
Income — dividend safety
Income & Dividend Safetycoverage over headline yield
~ BorderlinePassesPays a dividend$0.12 · > 0
FailsYield in a healthy band (not a yield trap)0.4% · 1.0%–8.0%
PassesCovered by free cash flow8.36 · ≥ 1.20
PassesEarnings payout not stretched20.3% · ≤ 75.0%
PassesBalance sheet can sustain the payout−0.7× · ≤ 4.0×
Decided by the pass rule for Income & Dividend Safety.The pass rule for Income & Dividend Safety is what decides that verdict, and it is not published separately on the methodology page.
Dividend Growthraises you can count on
— Insufficient inputs (2 of 6 known)PassesPays a dividend$0.12 · > 0
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)— · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
PassesCovered by free cash flow8.36 · ≥ 1.20
Unknown — no dataPayout not stretched— · ≤ 75.0%
Verdict Unknown for this set.Verdict Unknown for this set. 2 of 6 checks below carry data.Dividend Growth under The screens ›Today's Dividend Growth list ›
Long Hold — quality compounders
Quality Compounderhigh returns, reinvested, few new shares
✕ FailsFailsReturn on invested capital ≥ 15% in 4+ of the last 5 years0 of 4 on file
FailsRevenue compounding ≥ 8%/yr over 5 years4.4% per year · ≥ 8.0%
PassesNot diluting: diluted share count flat-to-down (≤ +1%/yr)−1.2% · ≤ 1.0%
FailsFree cash flow margin ≥ 12%10.2% · ≥ 12.0%
PassesEarnings backed by cash (operating cash flow ≥ net income)3.39 · ≥ 1.00
Reading: holds. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate check−1.2%
Decided by the pass rule for Quality Compounder.The pass rule for Quality Compounder is what decides that verdict, and it is not restated here. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›Today's Quality Compounder list ›
Timing — dip & swing receipts
Drawdown Contexta dip, not a collapse
~ BorderlineFailsOff its 52-week high by 8–35% (a dip, not a collapse)0.2% · 8.0%–35.0%
PassesDip within its own normal pullback band0.10
PassesNot past where its dips have historically recovered from−0.66
PassesA dip in an uptrend (above a rising 200-day)25.28
PassesHigher-low structure still intactstructure intact · higher low
PassesClear of the earnings blackout (more than 5 days out)7.00 · > 5.00
Decided by the pass rule for Drawdown Context.The pass rule for Drawdown Context is what decides that verdict, and it is not published separately on the methodology page.
Reversal Evidencedaily close onlysigns the pullback is turning
~ BorderlineFailsA bullish MACD cross within 10 sessions17.00 · ≤ 10.00
PassesReclaimed a rising 50-day EMA30.87
PassesPrinted a higher lowyes
FailsA volume thrust on the turn (≥ 1.2× normal)0.99 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)2.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page.
Not-a-Value-Trap Gatecheap for a good reason, not a broken one
✓ QualifiesPassesIn the cheap half of its own 5-year valuation range(through fiscal 2025)0.5×
Not scored: see the reason belowEarnings estimates not being cutThe 90-day estimate-revision window is still filling (2 days on record so far). The reading beside this line is real, but a window this short can reverse, so it is shown rather than scored.0.00
PassesReturns on capital not deteriorating0.05
Decided by the pass rule for Not-a-Value-Trap Gate.The pass rule for Not-a-Value-Trap Gate is what decides that verdict, and it is not published separately on the methodology page. 1 of 3 carry no data.
Quality Floorpasses the quality/value gate on this dip
~ BorderlinePassesOperating profit is positive(fiscal 2025: trailing figures for Technology are still under review)$20.2M · > 0
FailsReturn on invested capital ≥ 10%(TTM through Jun 30, 2026)5.6% · ≥ 10.0%
PassesA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)(TTM through Jun 30, 2026)4.9×
PassesQuality score ≥ 5053.20 · ≥ 50.00
PassesRevenue growing over 5 years(fiscal 2020 to 2025)4.4% per year · > 0
Decided by the pass rule for Quality Floor.The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page.
Qualified Dipa pullback with receipts, not a falling knife
~ BorderlineA research signal from published criteria, not a recommendation.
FailsDrawdown context0.2% off its 52-week high
FailsReversal evidence2 of 4 signals fired
PassesTrap gate2 of 3 held · 1 no data
FailsQuality floor4 of 5 held
Invalidation level (structure break): below this the dip's structure has broken$19.88
Decided by the pass rule for Qualified Dip.The pass rule for Qualified Dip is what decides that verdict, and it is not restated here.Qualified Dip under The screens ›Today's Qualified Dip list ›
Trend Alignmentprice in a confirmed uptrend
✓ QualifiesPassesTrading above its 50-day average30.39
PassesTrading above its 200-day average25.28
Passes50-day average above the 200-day (uptrend stack)30.39
Passes50-day average sloping up0.06 · > 0
Decided by the pass rule for Trend Alignment.The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page.
Relative Strengthoutperforming, ranked vs the universe
✓ QualifiesPasses3-month return in the top half of the universe0.92 · ≥ 0.50
Passes12-minus-1 momentum in the top half of the universe0.52 · ≥ 0.50
PassesRelative strength vs the S&P 500 improving0.00 · > 0
Not scored: see the reason belowEarnings estimates being revised upThe 90-day estimate-revision window is still filling (2 days on record so far). The reading beside this line is real, but a window this short can reverse, so it is shown rather than scored.0.00
Decided by the pass rule for Relative Strength.The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
Momentum Triggera trigger you can see
✕ FailsPassesMACD above its signal line1.27
FailsBack above the 50-day on a fresh cross (≤10 sessions)17.00
PassesHigher high and higher low (stair-stepping up)higher high · higher low
FailsA volume thrust on the move (≥ 1.2× normal)0.99 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page.
Volatility Regimecontext, not a signal
Context, not scoredAverage daily swing: normal0.02
Volatility band width: expanded (wide range)0.95
Distance from its 52-week high: at / near its highs0.00
✓
Every verdict is auditableEach criterion shows the live number and the pass rule side by side — a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
!
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.
Common questions
How many investing rule sets does Healthstream pass?
Healthstream qualifies on 3 of 17 rule sets as of 2026-10-26, with 8 borderline and 5 failing.
Does Healthstream meet the Graham Defensive criteria?
Healthstream fails the Graham Defensive rule set as of 2026-10-26.
Does Healthstream meet the Buffett Quality criteria?
Healthstream is borderline on the Buffett Quality rule set as of 2026-10-26.
Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.